Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

TELA Bio, Inc. (TELA) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

TELA Bio, Inc. (TELA), most recent 12 months reported: revenue $79.91M, net loss $41.18M, free cash flow -$31.62M. Latest balance sheet on file: liquid cash $30.42M, total debt $56.08M, net cash -$25.66M. From SEC filings. Others in Surgical & Medical Instruments & Apparatus: DELCATH SYSTEMS, INC. · PULMONX CORPORATION · IRADIMED CORPORATION · SIGHT SCIENCES, INC. · PRO-DEX, INC. · AVITA Medical, Inc. · Carlsmed, Inc. · MEIHUA INTERNATIONAL MEDICAL TECHNOLOGIES cO., LTD.

Stock screener

Watchlist